Soliman Ahmed M, Du Ella Xiaoyan, Yang Hongbo, Wu Eric Q, Haley Jane C
1 AbbVie, Inc. , North Chicago, Illinois.
2 Analysis Group, Inc. , Los Angeles, California.
J Womens Health (Larchmt). 2017 Jun;26(6):644-654. doi: 10.1089/jwh.2016.6043. Epub 2017 May 4.
Hysterectomy and laparoscopy are the two most common surgical options used to treat women with endometriosis, yet the disease may still recur. This study aimed to determine the long-term retreatment rates among endometriosis patients in the United States who received either hysterectomy or laparoscopy.
Patients aged 18-49 years with endometriosis who underwent hysterectomy or laparoscopy were identified in the Truven Health MarketScan claims database (2004-2013). The retreatment rate up to 8 years after the initial surgery was estimated using Kaplan-Meier survival analysis. The relative risk of retreatment among patients with hysterectomy versus laparoscopy was assessed using a Cox proportional hazard model.
A total of 24,915 patients with endometriosis who underwent hysterectomy and 37,308 patients with endometriosis who underwent laparoscopy were identified. The estimated retreatment rates were 3.3%, 4.7%, and 5.4% in the 2nd, 5th, and 8th year following hysterectomy, respectively, while the rates following laparoscopy were 15.8%, 27.5%, and 35.2%, respectively. The hazard ratio of retreatment was 0.157 (95% confidence interval [CI]: 0.146-0.169) comparing hysterectomy to laparoscopy. In the sensitivity analysis, which expanded the definition of retreatment by including medical treatments, the retreatment rate increased by a factor of 11-14 for the hysterectomy cohort and by a factor of 2-4 for the laparoscopy cohort, and the hazard ratio of retreatment rate for hysterectomy versus laparoscopy was 0.490 (95% CI: 0.477-0.502).
Our study results indicated that the disease retreatment rate after laparoscopy is high among patients with endometriosis; even hysterectomy does not guarantee freedom from retreatment.
子宫切除术和腹腔镜检查是用于治疗子宫内膜异位症女性的两种最常见的手术选择,但该疾病仍可能复发。本研究旨在确定在美国接受子宫切除术或腹腔镜检查的子宫内膜异位症患者的长期再次治疗率。
在Truven Health MarketScan理赔数据库(2004 - 2013年)中识别年龄在18 - 49岁且接受过子宫切除术或腹腔镜检查的子宫内膜异位症患者。使用Kaplan - Meier生存分析估计初次手术后长达8年的再次治疗率。使用Cox比例风险模型评估子宫切除术患者与腹腔镜检查患者再次治疗的相对风险。
共识别出24915例接受子宫切除术的子宫内膜异位症患者和37308例接受腹腔镜检查的子宫内膜异位症患者。子宫切除术后第2年、第5年和第8年的估计再次治疗率分别为3.3%、4.7%和5.4%,而腹腔镜检查后的再次治疗率分别为15.8%、27.5%和35.2%。子宫切除术与腹腔镜检查相比,再次治疗的风险比为0.157(95%置信区间[CI]:0.146 - 0.169)。在敏感性分析中,通过纳入药物治疗扩大了再次治疗的定义,子宫切除队列的再次治疗率增加了11 - 14倍,腹腔镜检查队列增加了2 - 4倍,子宫切除术与腹腔镜检查再次治疗率的风险比为0.490(95% CI:0.477 - 0.502)。
我们的研究结果表明,子宫内膜异位症患者腹腔镜检查后的疾病再次治疗率较高;即使是子宫切除术也不能保证免于再次治疗。